Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Michael Wattenbarger sold 7,141 shares of Addus HomeCare stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.67, for a total transaction of $890,268.47. Following the sale, the executive vice president directly owned 7,303 shares in the company, valued at $910,465.01. This trade represents a 49.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Addus HomeCare Price Performance
ADUS stock opened at $125.49 on Thursday. The company has a 50 day simple moving average of $118.19 and a 200 day simple moving average of $107.10. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 20.91, a P/E/G ratio of 1.66 and a beta of 0.75. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $131.59. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. During the same quarter in the prior year, the firm earned $1.56 EPS. The firm’s revenue was up 7.0% compared to the same quarter last year. Research analysts anticipate that Addus HomeCare Corporation will post 6.41 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages have recently commented on ADUS. Raymond James Financial set a $137.00 price target on Addus HomeCare in a research note on Monday, September 28th. TD Cowen boosted their price objective on Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Truist Financial upped their target price on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Finally, Bank of America cut Addus HomeCare from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $140.00 to $125.00 in a report on Monday, September 14th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $134.70.
Get Our Latest Analysis on Addus HomeCare
Trending Headlines about Addus HomeCare
Investors following ADUS have been watching these headlines:
- Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
- Neutral Sentiment: A report claims short interest was zero shares, despite describing it as a large increase. The conflicting wording makes the short-interest update difficult to interpret.
- Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Hsbc Holdings PLC increased its position in Addus HomeCare by 73.3% in the 2nd quarter. Hsbc Holdings PLC now owns 24,463 shares of the company’s stock valued at $2,446,000 after acquiring an additional 10,350 shares during the period. Summit Creek Advisors LLC bought a new position in shares of Addus HomeCare during the second quarter valued at $8,552,000. Globeflex Capital L P bought a new position in shares of Addus HomeCare during the second quarter valued at $1,635,000. Bank of America Corp DE lifted its holdings in shares of Addus HomeCare by 11.3% during the first quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after purchasing an additional 32,714 shares during the period. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of Addus HomeCare during the second quarter worth $901,000. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
